Literature DB >> 11223824

Pulmonary metastasectomy: might the type of resection affect survival?

T C Mineo1, V Ambrogi, G Tonini, I Nofroni.   

Abstract

BACKGROUND AND OBJECTIVES: Metastasectomy proved to be the choice treatment in the case of pulmonary metastasis. In this study we assessed the impact on survival of three types of resection: minimal by laser or conventional device and lobectomy.
METHODS: We considered 85 patients who underwent lung metastasectomy for tumors that originated from various sites. Fifty-two minimal resections were accomplished in 34 patients by conventional (diathermy dissection or stapler suture line) device, 59 resections in 29 by Nd:YAG laser. Lobectomies were 22. Minimum follow up required was 2 years.
RESULTS: The 3-year Kaplan-Meier survival rate was 63%, 44%, 53% for laser, conventional resections and lobectomy. The 5-year survival was 40%, 28%, 26% respectively. Among the groups there was no significant difference (P = 0.15). Laser patients showed shorter periods of air leakage and hospital stay.
CONCLUSIONS: The type of resection did not disclose statistically significant differences on survival. Minimal surgery, especially by laser device, is recommended for less morbidity.

Entities:  

Mesh:

Year:  2001        PMID: 11223824     DOI: 10.1002/1096-9098(200101)76:1<47::aid-jso1008>3.0.co;2-v

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  10 in total

1.  Lung metastasectomy: an experience-based therapeutic option.

Authors:  Tommaso Claudio Mineo; Vincenzo Ambrogi
Journal:  Ann Transl Med       Date:  2015-08

2.  [Radiofrequency ablation (RFA) of lung metastases from colorectal cancer (CRC)-one-year follow-up].

Authors:  K Steinke; J King; D Glenn; D L Morris
Journal:  Radiologe       Date:  2004-07       Impact factor: 0.635

3.  Uniportal non-intubated lung metastasectomy.

Authors:  Tommaso Claudio Mineo; Francesco Sellitri; Eleonora Fabbi; Vincenzo Ambrogi
Journal:  J Vis Surg       Date:  2017-09-14

4.  Role of systemic inflammation scores in pulmonary metastasectomy for colorectal cancer.

Authors:  Tommaso Claudio Mineo; Federico Tacconi
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

5.  Pulmonary metastasectomy in sarcoma-experiences with laser-assisted resection.

Authors:  Severin Schmid; Uyen-Thao Le; Christoph Zeisel; Benedikt Haager; Bernward Passlick
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

6.  Immunological and Inflammatory Impact of Non-Intubated Lung Metastasectomy.

Authors:  Tommaso Claudio Mineo; Francesco Sellitri; Gianluca Vanni; Filippo Tommaso Gallina; Vincenzo Ambrogi
Journal:  Int J Mol Sci       Date:  2017-07-07       Impact factor: 5.923

7.  Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma.

Authors:  Shuenn-Wen Kuo; Yih-Leong Chang; Pei-Ming Huang; Hsao-Hsun Hsu; Jin-Shin Chen; Jang-Ming Lee; Po-Huang Lee; Yung-Chie Lee
Journal:  Ann Surg Oncol       Date:  2006-12-06       Impact factor: 5.344

8.  Is open surgery necessary for metastatic pulmonary tumors evaluated with thorax tomography?

Authors:  Hüseyin Çakmak; Arif Osman Tokat; Sezgin Karasu
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

9.  Lung metastasectomy following kidney tumors: outcomes and prognostic factors from a single-center experience.

Authors:  Elisa Meacci; Dania Nachira; Maria Teresa Congedo; Venanzio Porziella; Marco Chiappetta; Gianmaria Ferretti; Amedeo Iaffaldano; Leonardo Petracca Ciavarella; Stefano Margaritora
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 10.  Integrating metastasectomy and stereotactic radiosurgery in the treatment of metastatic renal cell carcinoma.

Authors:  Axel Bex
Journal:  EJC Suppl       Date:  2013-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.